Physician profile
Kyle D Payne
NPI 1467660910
$5,611.09
in general payments reported to CMS, 2019-2025
23 companies · $58.09 in 2025
The $58.09 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,074 · 2020: $231 · 2021: $1,163 · 2022: $48.49 · 2023: $36.57 · 2025: $58.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $94.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $94.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,017.00 | 2019 | |
| Abbott Laboratories | $1,969.01 | 2019-2021 | |
| Abbvie INC. | $226.05 | 2021-2023 | |
| Medtronic USA, INC. | $168.70 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $155.01 | 2021 | |
| Gentleman Orthopedic Solutions | $123.32 | 2019 | |
| Scilex Pharmaceuticals INC. | $121.61 | 2021 | |
| Almatica Pharma LLC | $106.46 | 2021 | |
| Stimwave Technologies Incorporated | $99.49 | 2021 | |
| Lilly USA, LLC | $72.66 | 2021 | |
| Grt US Holding, INC. | $72.30 | 2021 | |
| Collegium Pharmaceutical, INC. | $72.04 | 2021 | |
| Mdd US Operations, LLC | $68.51 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.88 | 2019-2021 | |
| Daiichi Sankyo INC. | $49.57 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $48.83 | 2023-2025 | Bridion |
| Pacira Therapeutics, INC. | $47.06 | 2019-2021 | |
| Becton, Dickinson and Company | $25.02 | 2025 | Hemosphere |
| Medtronic, INC. | $23.48 | 2021 | |
| Radius Health, INC. | $22.29 | 2019 | |
| Nevro Corp. | $20.76 | 2019 | |
| Boston Scientific Corporation | $20.43 | 2021 | |
| Kaleo, INC. | $18.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.